Abiopharma

Change - Announcement of Cessation: Cessation of Group Chief Financial Officer

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement :: Half Yearly Results

Update on Claims against the Company

General Announcement: Update on Claims against the Company

General Announcement: Corrigendum on Announcement in relation to Enhanced Package for Affected Customers

Corrigendum on Announcement in relation to Enhanced Package for Affected Customers

New Form SCHEDULE 13G/A - Lexeo Therapeutics, Inc. Filed: 2025-08-14 AccNo: 0001274173-25-000249 Size: 10 KB

New Form SCHEDULE 13G/A - Benitec Biopharma Inc. Filed: 2025-08-14 AccNo: 0001274173-25-000247 Size: 10 KB

New Form SCHEDULE 13G/A - Forte Biosciences, Inc. Filed: 2025-08-14 AccNo: 0001274173-25-000248 Size: 10 KB

New Form SCHEDULE 13G/A - Edgewise Therapeutics, Inc. Filed: 2025-08-14 AccNo: 0001274173-25-000244 Size: 9 KB

New Form SCHEDULE 13G/A - Tyra Biosciences, Inc. Filed: 2025-08-14 AccNo: 0001274173-25-000243 Size: 9 KB

New Form SCHEDULE 13G/A - SENSIENT TECHNOLOGIES CORP Filed: 2025-08-14 AccNo: 0001274173-25-000242 Size: 9 KB

New Form SCHEDULE 13G/A - LIGAND PHARMACEUTICALS INC Filed: 2025-08-14 AccNo: 0001274173-25-000241 Size: 9 KB

New Form SCHEDULE 13G/A - Revolution Medicines, Inc. Filed: 2025-08-14 AccNo: 0001274173-25-000239 Size: 9 KB